Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
carbonic anhydrase inhibitor |
| gptkbp:approvalYear |
1995
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01EC03
|
| gptkbp:CASNumber |
120279-96-1
|
| gptkbp:chemicalFormula |
C10H16N2O4S3
|
| gptkbp:combines |
gptkb:timolol
|
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| https://www.w3.org/2000/01/rdf-schema#label |
dorzolamide
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits carbonic anhydrase II
|
| gptkbp:molecularWeight |
324.44 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:reduces |
intraocular pressure
|
| gptkbp:routeOfAdministration |
topical (eye drops)
|
| gptkbp:sideEffect |
blurred vision
bitter taste eye irritation |
| gptkbp:synonym |
gptkb:Dorzolamide_hydrochloride
gptkb:Trusopt |
| gptkbp:usedFor |
glaucoma
ocular hypertension |
| gptkbp:bfsParent |
gptkb:Cosopt
gptkb:Trusopt |
| gptkbp:bfsLayer |
5
|